Nanogen Announces Combination with The Elitech Group

Nanogen, Inc. (NASDAQ: NGEN), developer of molecular and rapid in vitro diagnostic products, and The Elitech Group, a private French diagnostics company, announced a definitive agreement to combine the two companies. The combination will create a global provider of products to the molecular, point-of-care, clinical chemistry and microbiology diagnostics markets with expected first year revenues of more than $150 million and positive EBITDA.

Source: Nanogen